Renshi Xu

Prof. Renshi Xu

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2006 in Stem Cells
Verified
Journal Article
Open access
PDF file
YKYan Ke
Yan Ke
LCLiying Chi
Liying Chi
RXRenshi Xu
Renshi Xu
CLChun Luo
Chun Luo
DGDavid Gozal
David Gozal
RLRugao Liu
Rugao Liu
Adult neural progenitor cells (NPCs) are an attractive source for functional replacement in neurodegenerative diseases and traumatic injury to the central nervous system (CNS). It has been shown that transplantation of neural stem cells or NPCs into the lesioned region partially restores CNS function. However, the capacity of endogenous NPCs in replacement of neuronal cell loss and functional recovery of spinal cord injury (SCI) is apparently poor. Furthermore, the temporal and spatial response of endogenous adult NPCs to SCI remains largely undefined. To this end, we have analyzed the early organization, distribution, and potential function of NPCs in response to SCI, using nestin enhancer (promoter) controlled LacZ reporter transgenic mice. We showed that there was an increase of NPC proliferation, migration, and neurogenesis in adult spinal cord after traumatic compression SCI. The proliferation of NPCs detected by 5-bromodeoxyuridine incorporation and LacZ staining was restricted to the ependymal zone (EZ) of the central canal. During acute SCI, NPCs in the EZ of the central canal migrated vigorously toward the dorsal direction, where the compression lesion is generated. The optimal NPC migration occurred in the adjacent region close to the epicenter. More significantly, there was an increased de novo neurogenesis from NPCs 24 hours after SCI. The enhanced proliferation, migration, and neurogenesis of (from) endogenous NPCs in the adult spinal cord in response to SCI suggest a potential role for NPCs in attempting to restore SCI-mediated neuronal dysfunction.

8 July 2021 in Neural Regeneration Research
Verified
Journal Article
Open access
PDF file
YZYu Zhu
Yu Zhu
MYMin Yuan
Min Yuan
YLYue Liu
Yue Liu
FYFang Yang
Fang Yang
WCWen-Zhi Chen
Wen-Zhi Chen
RXRenshi Xu
Renshi Xu
Growing evidence suggests that there are similar pathological mechanisms and closely related pathogenic risk factors for inflammatory bowel disease (IBD) and Parkinson's disease (PD). However, the epidemiological features of these two diseases are different. This review systematically evaluated the relationship between inflammatory bowel diseases and Parkinson's disease risk. We searched PubMed, Embase, and Cochrane databases to retrieve observational studies of IBD and PD published from inception to October 2019. Nine observational studies, involving 12,177,520 patients, were included in the final analysis. None of the studies had Newcastle–Ottawa Scale scores that suggested a high risk of bias. After adjusting for confounders and excluding heterogeneous studies, the overall risk of PD was significantly higher in IBD patients than in the general population (adjusted risk ratio [RR] = 1.24, 95% confidence interval [CI]: 1.15–1.34, P < 0.001). A meta-analysis of the temporal relationship revealed that the incidence of IBD was significantly increased before (adjusted hazard ratio [HR] = 1.26, 95% CI: 1.18–1.35, P < 0.001) and after (adjusted RR = 1.40, 95% CI: 1.20–1.80, P < 0.001) PD diagnosis. After excluding a heterogeneous study, the pooled risk of PD development in patients with ulcerative colitis (adjusted HR = 1.25, 95% CI: 1.13–1.38, P < 0.001) or Crohn's disease (adjusted HR = 1.33, 95% CI: 1.21–1.45, P < 0.01) was significantly increased. Subgroup analysis revealed no significant differences in risk between men (adjusted HR = 1.23, 95% CI: 1.10–1.39) and women (adjusted HR = 1.26, 95% CI: 1.10–1.43); however, older (> 65 years old) IBD patients (adjusted HR = 1.32, 95% CI: 1.17–1.48) may have a higher risk than younger (≤ 65 years old) patients (adjusted HR = 1.24, 95% CI: 1.08–1.42). Patients with IBD who were not treated with anti-tumor necrosis factor-α or azathioprine had significantly higher PD risk (adjusted HR = 1.6, 95% CI: 1.2–2.2). Thus, our meta-analysis indicates a certain correlation between IBD and PD, and suggests that IBD may moderately increase PD risk regardless of sex, especially in patients over 65 years of age. Moreover, early anti-inflammatory therapies for IBD might reduce the risk of developing PD. Our findings suggest an urgent need for an individualized screening strategy for patients with IBD. However, most studies included in this paper were observational, and more randomized controlled trials are needed to confirm the precise association between IBD and PD.

1 January 2020 in International Journal of Biological Sciences
Verified
Journal Article
Open access
QZQi Zhou
Qi Zhou
LZLei Zhu
Lei Zhu
WQWeiwen Qiu
Weiwen Qiu
YLYue Liu
Yue Liu
FYFang Yang
Fang Yang
RXRenshi Xu
Renshi Xu
Amyotrophic lateral sclerosis (ALS) is caused by the progressive degeneration of motor neurons in the spinal cord, the brain stem, and the motor cortex. So far, there is still a lack of effective drugs. Nicotinamide adenine dinucleotide (NAD+) takes part in redox reactions and the NAD-dependent signaling pathway. The NAD+ decline is related with many neurological diseases, leading to the accumulation of neurotoxic protein in the central nervous system. Moreover, the NAD+ supplementation is shown to promote neural stem cells/neuronal precursor cells (NSCs/NPCs) pool maintenance. Regulatory mechanisms and functions of NAD+ metabolism in ALS are still unknown. Thus, we hypothesized the aggregation of human SOD1 toxic protein and the fate of NSCs/NPCs in the ALS disease could be improved by the administration of nicotinamide riboside (NR), an NAD+ precursor. In this study, we treated SOD1G93A transgenic and wild-type mice by the oral administration of 20 mg/ml NR starting at 50 days of age. Effects of NR on the body weight, the motor function, the onset and the survival were assessed during the experiment. The expression of mutant hSOD1 protein, mitochondrial unfolded protein response (UPRmt) related protein, mitophagy markers and NAD+ metabolism related protein were detected by immunoblotting. Effects of NR on the NSCs/NPCs in neurogenic niches of brain were identified by the immunofluorescence staining. Our investigation elucidated that the NR treatment exhibited better hanging wire endurance but did not postpone the onset or extend the life span of SOD1G93A mice. Besides, we observed that the NR repletion promoted the clearance of mitochondrial hSOD1 neurotoxic protein. Meanwhile, the mitochondrial function pathway was disrupted in the brain of SOD1G93A mice. What's more, we demonstrated that the inadequate function of NAD+ salvage synthesis pathway was the primary explanation behind the decline of NAD+, and the NR treatment enhanced the proliferation and migration of NSCs/NPCs in the brain of SOD1G93A mice. At last, we found that levels of UPRmt related protein were significantly increased in the brain of SOD1G93A mice after the NR treatment. In summary, these findings reveal that the administration of NR activates UPRmt signaling, modulates mitochondrial proteostasis and improves the adult neurogenesis in the brain of SOD1G93A mice.

1 January 2014 in Neuroscience Letters
Verified
Journal Article
Closed access
FZFuqing Zhou
Fuqing Zhou
RXRenshi Xu
Renshi Xu
EDEmily Dowd
Emily Dowd
YZYu-Feng Zang
Yu-Feng Zang
HGHonghan Gong
Honghan Gong
Ze WangZe Wang
Ze Wang

1 July 2014 in Neurobiology of Aging
Verified
Journal Article
Closed access
TXTong Xie
Tong Xie
LDLibin Deng
Libin Deng
PMPuming Mei
Puming Mei
YZYiyi Zhou
Yiyi Zhou
BWBo Wang
Bo Wang
RXRenshi Xu
Renshi Xu

21 August 2013 in NeuroReport
Verified
Journal Article
Closed access
FZFuqing Zhou
Fuqing Zhou
HGHonghan Gong
Honghan Gong
FLFangjun Li
Fangjun Li
YZYing Zhuang
Ying Zhuang
YZYu-Feng Zang
Yu-Feng Zang
Ze WangZe Wang
Ze Wang
Resting-state functional MRI provides a viable tool for assessing brain dysfunctions in amyotrophic lateral sclerosis (ALS) without using explicit tasks. Altered resting brain functional connectivity (FC) in ALS has been reported in several studies but with large discrepancies in terms of the alteration directions. The purpose of this study was to provide new evidence for the resting FC disruptions in ALS. We focused on FC in the motor network as motor dysfunctions are a hallmark of ALS pathology. To test the hypothesis that ALS is associated with intermotor network FC changes, we compared FC of the key nodes of motor network between 12 ALS patients and 12 matched controls, and found both decreased and increased within-motor network FC in ALS patients. Increased FC between the bilateral superior parietal lobule and the right anterior inferior cerebellum was found to be correlated with disease severity, with higher FC related to more severe disease. The decreased motor network FC may be a result of motor function degradation in ALS, whereas the increased FC and its correlation to disease severity might suggest a brain mechanism to compensate the loss of the normal motor functionality in ALS. Our results also showed that the within-motor cortex FC except the within premotor area FC did not change in these early disease stage patients.